← Leaderboards
Kathryn Kosuda
Vaxess Technologies, Inc.
$5,352,613
Attributed
$5,352,613
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2015–23$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,352,613 · 3
By mechanism
SB1$2,845,449 · 1
R44$2,297,098 · 1
R43$210,066 · 1
Top collaborators
No co-investigators on record.
Most similar at Vaxess Technologies, Inc.
Same institution · by research overlap
- Lynda Tussey$335,410
- Kathryn Kosuda$256,000
Others in their field
Top investigators on “Silk”
- David L Kaplan · Tufts University Medford$24,168,066
- Pamela C Yelick · Forsyth Institute$7,313,573
- Randall J Bateman · Washington University$6,505,432
- Lashanda T Korley · Case Western Reserve University$5,642,795
- Gordana Vunjak-Novakovic · Tufts University Medford$5,488,745
- Joshua Robert Mauney · University Of California-Irvine$4,935,209
Research focus
SilkBiocompatible MaterialsVaccinesAntigensAnimal ModelMeetingsResponseTechnologyImmunizationFibroinsInfluenza VaccinationImmune ResponseBaseInfectionAntibodiesCenters For Disease Control And Prevention (U.S.)InfluenzavirusEngineeringBody TemperatureDevicesAnti-InfluenzaBurden Of IllnessDermisDesign
Grant awards (7)
Microarray Patch for Broadly Protective Seasonal Influenza Vaccination$845,449
SB1 · FY2023 · AI · contact PI
Microarray Patch for Broadly Protective Seasonal Influenza Vaccination$1,000,000
SB1 · FY2022 · AI · contact PI
Microarray Patch for Broadly Protective Seasonal Influenza Vaccination$1,000,000
SB1 · FY2021 · AI · contact PI
Improved Influenza Vaccine Efficacy Through Infection Mimicry$999,900
R44 · FY2021 · AI · contact PI
Improved Influenza Vaccine Efficacy Through Infection Mimicry$997,500
R44 · FY2020 · AI · contact PI
Improved Influenza Vaccine Efficacy Through Infection Mimicry$299,698
R44 · FY2019 · AI · contact PI
Development of a Silk-Stabilized Inactivated Polio Vaccine$210,066
R43 · FY2015 · AI · contact PI